- decreased circulating LDL cholesterol level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- abnormal skin condition / IMPC
- decreased circulating alanine transaminase level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- thrombocytosis / IMPC
- decreased circulating aspartate transaminase level / IMPC
- preweaning lethality, complete penetrance / IMPC
- hyperplasia / IMPC
- lipid deposition / IMPC
- extramedullary hemopoiesis / IMPC
C57BL/6NTac-Sar1btm1a(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:05863 |
Citation information | RRID:IMSR_EM:05863 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6NTac-Sar1btm1a(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0113_3_C11 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Sar1btm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Sar1b |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0113_3_C11. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac males |
Breeding at archiving centre | Frozen material received. |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Chylomicron retention disease / Orphanet_71
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- hyperplasia / IMPC
- decreased circulating aspartate transaminase level / IMPC
- lipid deposition / IMPC
- thrombocytosis / IMPC
- extramedullary hemopoiesis / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal skin condition / IMPC
- decreased circulating serum albumin level / IMPC
- decreased circulating alanine transaminase level / IMPC
- decreased circulating LDL cholesterol level / IMPC
- preweaning lethality, complete penetrance / IMPC
MGI phenotypes (allele matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal skin condition / MGI
- increased circulating free fatty acid level / MGI
- decreased circulating free fatty acid level / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- increased mean corpuscular hemoglobin / MGI
MGI phenotypes (gene matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- abnormal skin condition / MGI
- increased circulating free fatty acid level / MGI
- decreased circulating free fatty acid level / MGI
- decreased circulating alanine transaminase level / MGI
- decreased circulating cholesterol level / MGI
- increased mean corpuscular hemoglobin / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).